Advertisement
Advertisement
U.S. markets close in 3 hours 12 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Fresenius SE & Co. KGaA (FRE.DE)

XETRA - XETRA Delayed Price. Currency in EUR
Add to watchlist
28.53-0.79 (-2.69%)
At close: 05:35PM CEST
Advertisement
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close29.32
Open29.45
Bid28.65 x N/A
Ask28.67 x N/A
Day's Range28.53 - 29.49
52 Week Range26.52 - 47.60
Volume1,094,274
Avg. Volume1,058,611
Market Cap15.963B
Beta (5Y Monthly)1.21
PE Ratio (TTM)8.89
EPS (TTM)3.21
Earnings DateAug 02, 2022
Forward Dividend & Yield0.92 (3.16%)
Ex-Dividend DateMay 16, 2022
1y Target Est44.69
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for FRE.DE

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • Reuters

      Fresenius warns of bigger Ukraine war impact after Q1 profit beat

      German healthcare group Fresenius's first-quarter profit exceeded market expectations on Wednesday, driven by growth in its generic infusion drugs unit in emerging markets. However, the group warned cost inflation and supply chain disruptions were likely to increase this year, fuelled by Russia's invasion of Ukraine. Fresenius's businesses include the Helios hospital chain, drugmaker Kabi, medical services firm Vamed and dialysis specialist Fresenius Medical Care (FMC).

    • InvestorPlace

      7 Stocks to Buy for the Coming Risk-On Rally

      The Russian invasion of Ukraine has brought the terms risk-on and risk-off into play as investors try to figure out the best stocks to buy in such a volatile market. A war of such magnitude is a headwind for stocks. As such, they’re currently considered risk-on assets. In times like these, investors look for risk-off assets such as gold, U.S. dollars, dollar-denominated bonds, and even Bitcoin (BTC-USD). The reality is that, try as we may, there is no such thing as a risk-off or risk-on asset. T

    • Moody's

      Fresenius Finance Ireland II Plc -- Moody's announces completion of a periodic review of ratings of Fresenius SE & Co. KGaA

      Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of Fresenius SE & Co. KGaAGlobal Credit Research - 08 Dec 2021Frankfurt am Main, December 08, 2021 -- Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of Fresenius SE & Co. KGaA and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review discussion held on 6 December 2021 in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers. Since 1 January 2019, Moody's practice has been to issue a press release following each periodic review to announce its completion.This publication does not announce a credit rating action and is not an indication of whether or not a credit rating action is likely in the near future.

    Advertisement
    Advertisement